Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ NPAT Recombinant Protein Antigen
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Supplier: Novus Biologicals™ NBP258659PEP
Description
A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human NPAT. Source: E.coli Amino Acid Sequence: VNQAVSPNFSQGSAIIIASPVQPVLQGMVGMIPVSVVGQNGNNFSTPPRQVLHMPLTAPVCNRSIPQFPVPPKSQKAQGLRNKPCIGKQVNNLVDSSGHSV The NPAT Recombinant Protein Antigen is derived from E. coli. The NPAT Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.Specifications
| 4863 | |
| NPAT Recombinant Protein Antigen | |
| PBS and 1M Urea, pH 7.4. | |
| CAND3, E14, E14/NPAT, Nuclear Protein Of The Ataxia Telangiectasia Mutated Locus, Nuclear Protein Of The ATM Locus, Nuclear Protein, Ataxia-Telangiectasia Locus, Nuclear Protein, Coactivator Of Histone Transcription, Nuclear Protein, Co-Activator Of Histo | |
| Unlabeled | |
| 100μL | |
| E.coli |
| >80% by SDS-PAGE and Coomassie blue staining | |
| Store at −20°C. Avoid freeze-thaw cycles. | |
| Blocking/Neutralizing, Control | |
| NPAT | |
| Recombinant Protein Antigen | |
| RUO | |
| Human |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only.